DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE:THC) released its Outlook for 2015.
The company expects its Adjusted EBITDA for 2015 to be in a range of
$2.05 billion to $2.15 billion. The company expects its Adjusted EBITDA
to be toward the top of its previously issued Outlook range of $1.90
billion to $1.95 billion for 2014.
“I am pleased with Tenet’s strong volume growth in the fourth quarter,”
said Trevor Fetter, president and chief executive officer. “We are
confident that our strategies will drive continued growth in our
hospitals and outpatient facilities and that our Conifer subsidiary will
become an even better partner for Tenet and other health systems seeking
to improve quality and lower the total cost of care for patients. We
look forward to building on the strong performance we achieved
throughout 2014.”
Preliminary Fourth Quarter 2014 Volume Metrics
In the fourth quarter, Tenet achieved same-hospital adjusted admissions
growth of an estimated 4.8 percent and inpatient admissions growth of
4.0 percent compared to the fourth quarter of 2013. Outpatient visits
increased by an estimated 9.5 percent. The company’s robust admissions
growth trend included continuing strong growth in commercial admissions,
setting another quarterly commercial growth record with the largest
increase in same-hospital commercial growth in more than a decade.
Paying admissions increased by 6.1 percent in the quarter.
Payer mix in the fourth quarter of 2014 also sustained the strengthening
trend established earlier in the year. In the five states that expanded
Medicaid eligibility under the Affordable Care Act, Tenet achieved a
decline in uninsured plus charity admissions of 2,547 admissions, or
62.4 percent, and an increase in Medicaid admissions of 4,355
admissions, or 20.5 percent. Across the entire company, including those
states that did not expand Medicaid, uninsured plus charity admissions
declined by 3,109 admissions, or 21.9 percent, in the fourth quarter,
while Medicaid admissions increased by 4,555 admissions, or 9.0 percent.
Exchange volumes continued to grow with 3,768 exchange admissions in the
fourth quarter, an increase of 373 exchange admissions, or 11.0 percent,
as compared to 3,395 same-hospital exchange admissions in the third
quarter of 2014.
California Provider Fee Program
In the fourth quarter of 2014, the Centers for Medicare and Medicaid
Services approved the California Provider Fee program for the three year
period January 1, 2014 through December 31, 2016. As a result, the
company will recognize approximately $165 million of total company net
revenue from the program in the fourth quarter of 2014 ($150 million of
same-hospital revenue) and approximately $170 million in 2015 ($155
million of same-hospital revenue).
2015 Outlook
Based on current market conditions and expectations, for the calendar
year 2015 Tenet anticipates:
-
Adjusted EBITDA of $2.05 billion to $2.15 billion
-
Net revenues of $17.4 billion to $17.7 billion,
-
Adjusted earnings per share of $1.32 to $2.40 per share,
-
Adjusted cash flow from operations of $1.150 billion to $1.250 billion,
-
Capital expenditures of $900 million to $1.0 billion,
-
Adjusted free cash flow of $150 million to $350 million.
-
Bad debt ratio of 6.75 to 7.25 percent of revenues,
-
California Provider Fee program net revenues of $170 million, and,
-
A $50 million decline in healthcare information technology incentives.
This expected performance is based on the following assumptions
(same-hospital):
-
Admissions growth of 1.5 to 2.5 percent,
-
Adjusted admissions growth of 2.5 to 3.5 percent,
-
Exchange volume growth of 60 to 80 percent,
-
Net revenue per adjusted admission growth of 1.0 to 2.0 percent,
-
Controllable expenses per adjusted admission growth of zero to 1.0
percent.
Webcast Presentation and Q&A Session
Tenet management will discuss the company’s 2015 Outlook and provide a
general strategic update at the 33rd Annual J.P. Morgan
Healthcare Conference today at 11:00 a.m. (CST). Investors can access
the live webcast of this presentation through Tenet’s website at www.tenethealth.com/investors.
The Q&A session that follows the presentation at 11:30 a.m. (CST) will
also be webcast and available through Tenet’s website. A set of slides
which will be referred to in this presentation is available on the
investor relations section of the company’s website.
About Tenet Healthcare
Tenet Healthcare Corporation is a national, diversified healthcare
services company with more than 105,000 employees united around a common
mission: to help people live happier, healthier lives. The company
operates 80 hospitals, more than 210 outpatient centers, six health
plans and Conifer Health Solutions, a leading provider of healthcare
business process services in the areas of revenue cycle management,
value based care and patient communications. For more information,
please visit www.tenethealth.com.
The terms "THC", "Tenet Healthcare Corporation", "the company", "we",
"us" or "our" refer to Tenet Healthcare Corporation or one or more of
its subsidiaries or affiliates as applicable.
This release contains “forward-looking statements” – that is, statements
that relate to future, not past, events. In this context,
forward-looking statements often address our expected future business
and financial performance and financial condition, and often contain
words such as “expect,” “assume,” “anticipate,” “intend,” “plan,”
“believe,” “seek,” “see,” or “will.” Forward-looking statements by their
nature address matters that are, to different degrees, uncertain.
Particular uncertainties that could cause our actual results to be
materially different than those expressed in our forward-looking
statements include, but are not limited to, the factors disclosed under
“Forward-Looking Statements” and “Risk Factors” in our Form 10-K for the
year ended December 31, 2013, and in our quarterly reports on Form 10-Q,
periodic reports on Form 8-K and other filings with the Securities and
Exchange Commission. The information contained in this release is as of
the date hereof. The company assumes no obligation to update
forward-looking statements contained in this release as a result of new
information or future events or developments.
Tenet uses its company website to provide important information to
investors about the company including the posting of important
announcements regarding financial performance and corporate developments.
|
|
|
Table #1 - Reconciliation of Outlook Adjusted EBITDA to
Outlook Net Income Attributable to Tenet Healthcare Corporation
Common Shareholders
for the Year Ending December 31, 2015
|
|
(Unaudited)
|
|
|
|
(Dollars in millions)
|
|
|
|
|
2015
|
|
|
|
|
|
|
Low
|
High
|
|
Net income (loss) attributable to Tenet Healthcare Corporation
common shareholders
|
|
|
|
|
$
|
130
|
|
$
|
245
|
|
|
Less:
|
|
|
|
|
|
|
|
Net (income) loss attributable to noncontrolling interests
|
|
|
|
|
|
(120
|
)
|
|
(100
|
)
|
|
Income (loss) from discontinued operations, net of tax
|
|
|
|
|
|
(5
|
)
|
|
0
|
|
|
Income from continuing operations
|
|
|
|
|
$
|
255
|
|
$
|
345
|
|
|
Income tax expense
|
|
|
|
|
|
(95
|
)
|
|
(175
|
)
|
|
Income from continuing operations, before income taxes
|
|
|
|
|
$
|
350
|
|
$
|
520
|
|
|
Interest expense, net
|
|
|
|
|
|
(800
|
)
|
|
(770
|
)
|
|
Operating income
|
|
|
|
|
$
|
1,150
|
|
$
|
1,290
|
|
|
Impairment and restructuring charges, acquisition-related and
litigation costs (a)
|
|
|
|
|
|
-
|
|
|
-
|
|
|
Depreciation and amortization
|
|
|
|
|
|
(900
|
)
|
|
(860
|
)
|
|
Adjusted EBITDA
|
|
|
|
|
$
|
2,050
|
|
$
|
2,150
|
|
|
Net Operating Revenues
|
|
|
|
|
$
|
17,400
|
|
$
|
17,700
|
|
|
|
|
|
|
Adjusted EBITDA as a % of net operating revenues (Adjusted
EBITDA margin)
|
|
|
|
|
|
11.8
|
%
|
|
12.1
|
%
|
|
|
|
(a) Company does not forecast impairment and restructuring charges,
acquisition-related and litigation costs
|
|
|
|
|
|
TENET HEALTHCARE CORPORATION
Additional Supplemental Non-GAAP Disclosures
Table #2 - Reconciliation of Outlook Adjusted EBITDA to
Outlook Normalized Income from Continuing Operations
for the Year Ending December 31, 2015
|
|
(Unaudited)
|
|
|
|
(Dollars in millions except per share amounts)
|
|
|
|
|
2015
|
|
|
|
|
|
|
Low
|
High
|
|
Adjusted EBITDA
|
|
|
|
|
$
|
2,050
|
|
$
|
2,150
|
|
|
Depreciation and amortization
|
|
|
|
|
|
(900
|
)
|
|
(860
|
)
|
|
Interest expense, net
|
|
|
|
|
|
(800
|
)
|
|
(770
|
)
|
|
Normalized income from continuing operations before income taxes
|
|
|
|
|
$
|
350
|
|
$
|
520
|
|
|
Income tax expense
|
|
|
|
|
|
(95
|
)
|
|
(175
|
)
|
|
Normalized income from continuing operations
|
|
|
|
|
$
|
255
|
|
$
|
345
|
|
|
Net (income) attributable to noncontrolling interests
|
|
|
|
|
|
(120
|
)
|
|
(100
|
)
|
|
Normalized net income attributable to common shareholders
|
|
|
|
|
$
|
135
|
|
$
|
245
|
|
|
|
|
|
|
|
|
|
|
Fully diluted weighted average share outstanding (in millions)
|
|
|
|
|
|
102
|
|
|
102
|
|
|
|
|
|
|
|
|
|
|
Normalized fully diluted earnings per share – continuing
operations
|
|
|
|
|
$
|
1.32
|
|
$
|
2.40
|
|
|
|
|
|
|
TENET HEALTHCARE CORPORATION
Additional Supplemental Non-GAAP Disclosures
Table #3 - Reconciliation of Outlook Adjusted Free Cash Flow
for the Year Ending December 31, 2015
|
|
(Unaudited)
|
|
|
|
(Dollars in millions)
|
2015
|
|
|
Low
|
High
|
|
Net cash provided by operating activities
|
$
|
1,130
|
|
$
|
1,240
|
|
|
Less:
|
|
|
|
|
|
|
|
Payments for restructuring charges, acquisition-related costs and
|
|
|
|
|
|
|
|
litigation costs and settlements
|
|
-
|
|
|
-
|
|
|
Net cash used in operating activities from discontinued operations
|
|
(20
|
)
|
|
(10
|
)
|
|
Adjusted net cash provided by operating activities – continuing
operations
|
$
|
1,150
|
|
$
|
1,250
|
|
|
Purchases of property and equipment – continuing operations
|
|
(1,000
|
)
|
|
(900
|
)
|
|
Adjusted free cash flow – continuing operations
|
$
|
150
|
|
$
|
350
|
|
|
|
